Skip to main content
. 2024 Jul 23;53:101473. doi: 10.1016/j.ijcha.2024.101473

Fig. 3.

Fig. 3

Fluorine-18 fluorodeoxyglucose positron emission tomography at baseline and follow up. Fluorine-18 fluorodeoxyglucose positron emission tomography was performed in 17 patients (65.4% of enrolled patients) at baseline and was repeated after administering nonsteroidal immunosuppressants in 16 patients (61.5% of enrolled patients). Fluorodeoxyglucose uptake was observed in 17 patients (65.4% enrolled, 100% performed) and 10 patients (38.5% enrolled, 62.5% performed) at follow-up.